Insider Buying: The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Major Shareholder Acquires $16,649.50 in Stock

Posted by Dante Gardener on Oct 10th, 2026

The Gabelli Healthcare & Wellness Trust (NYSE:GRX – Get Free Report) major shareholder Saba Capital Management, L.P. purchased 1,775 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The stock was acquired at an average price of $9.38 per share, with a total value of $16,649.50. Following the completion of the purchase, the insider owned 2,164,547 shares in the company, valued at $20,303,450.86. This represents a 0.08% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

On Wednesday, October 7th, Saba Capital Management, L.P. acquired 2,955 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were acquired at an average cost of $9.43 per share, for a total transaction of $27,865.65.
On Tuesday, October 6th, Saba Capital Management, L.P. bought 4,439 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were acquired at an average cost of $9.41 per share, with a total value of $41,770.99.
On Thursday, October 1st, Saba Capital Management, L.P. bought 5,720 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were acquired at an average price of $9.41 per share, with a total value of $53,825.20.
On Friday, October 2nd, Saba Capital Management, L.P. purchased 500 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was bought at an average cost of $9.35 per share, for a total transaction of $4,675.00.
On Wednesday, September 30th, Saba Capital Management, L.P. purchased 519 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was bought at an average price of $9.52 per share, for a total transaction of $4,940.88.
On Friday, September 11th, Saba Capital Management, L.P. acquired 400 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were bought at an average price of $9.71 per share, with a total value of $3,884.00.
On Thursday, September 3rd, Saba Capital Management, L.P. bought 500 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was bought at an average cost of $10.08 per share, for a total transaction of $5,040.00.
On Thursday, August 27th, Saba Capital Management, L.P. bought 4,340 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was bought at an average cost of $10.05 per share, for a total transaction of $43,617.00.
On Friday, August 21st, Saba Capital Management, L.P. purchased 7,087 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was bought at an average cost of $10.13 per share, with a total value of $71,791.31.
On Wednesday, August 19th, Saba Capital Management, L.P. purchased 24,102 shares of The Gabelli Healthcare & Wellness Trust stock. The stock was purchased at an average price of $10.13 per share, for a total transaction of $244,153.26.

The Gabelli Healthcare & Wellness Trust Price Performance

Shares of GRX stock opened at $9.64 on Friday. The Gabelli Healthcare & Wellness Trust has a one year low of $8.80 and a one year high of $10.20. The company’s 50-day moving average is $9.82 and its 200 day moving average is $9.43.

The Gabelli Healthcare & Wellness Trust Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Investors of record on Wednesday, September 16th were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $0.68 annualized dividend and a dividend yield of 7.1%.

Institutional Trading of The Gabelli Healthcare & Wellness Trust

Institutional investors and hedge funds have recently modified their holdings of the business. Sit Investment Associates Inc. lifted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 23.7% during the fourth quarter. Sit Investment Associates Inc. now owns 1,031,350 shares of the investment management company’s stock valued at $9,932,000 after purchasing an additional 197,594 shares in the last quarter. Gamco Investors INC. ET AL raised its position in The Gabelli Healthcare & Wellness Trust by 1.1% in the 1st quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock worth $3,132,000 after buying an additional 3,800 shares during the last quarter. Aviance Capital Partners LLC lifted its stake in The Gabelli Healthcare & Wellness Trust by 2.1% during the 1st quarter. Aviance Capital Partners LLC now owns 171,325 shares of the investment management company’s stock valued at $1,550,000 after acquiring an additional 3,482 shares during the period. Uhlmann Price Securities LLC boosted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 22.0% during the 1st quarter. Uhlmann Price Securities LLC now owns 61,590 shares of the investment management company’s stock valued at $557,000 after acquiring an additional 11,088 shares during the last quarter. Finally, Private Advisor Group LLC grew its stake in shares of The Gabelli Healthcare & Wellness Trust by 25.2% in the first quarter. Private Advisor Group LLC now owns 19,888 shares of the investment management company’s stock worth $180,000 after acquiring an additional 4,000 shares during the period.

The Gabelli Healthcare & Wellness Trust Company Profile

(Get Free Report)

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a diversified, closed-end investment company focused on long-term growth of capital. Rather than operating healthcare facilities or selling consumer products, the trust invests in publicly traded companies involved in healthcare and wellness.

Its portfolio may include businesses across areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, managed care, diagnostics, consumer health and wellness products, and related industries.